HLA-Associated Viral Mutations Are Common in Human Immunodeficiency Virus Type 1 Elite Controllers

Author's Correction ( vol. 84 , p. 1212 ) Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribe...

Full description

Saved in:
Bibliographic Details
Published inJournal of Virology Vol. 83; no. 7; pp. 3407 - 3412
Main Authors Miura, Toshiyuki, Brumme, Chanson J., Brockman, Mark A., Brumme, Zabrina L., Pereyra, Florencia, Block, Brian L., Trocha, Alicja, John, Mina, Mallal, Simon, Harrigan, P. Richard, Walker, Bruce D.
Format Journal Article
LanguageEnglish
Published Washington, DC American Society for Microbiology 01.04.2009
American Society for Microbiology (ASM)
Subjects
Online AccessGet full text
ISSN0022-538X
1098-5514
1098-5514
DOI10.1128/JVI.02459-08

Cover

Abstract Author's Correction ( vol. 84 , p. 1212 ) Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0022-538X Online ISSN: 1098-5514 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to JVI .asm.org, visit: JVI       
AbstractList Elite controllers (EC) of human immunodeficiency virus type 1 (HIV-1) maintain viremia below the limit of detection without antiretroviral treatment. Virus-specific cytotoxic CD8(+) T lymphocytes are believed to play a crucial role in viral containment, but the degree of immune imprinting and compensatory mutations in EC is unclear. We obtained plasma gag, pol, and nef sequences from HLA-diverse subjects and found that 30 to 40% of the predefined HLA-associated polymorphic sites show evidence of immune selection pressure in EC, compared to approximately 50% of the sites in chronic progressors. These data indicate ongoing viral replication and escape from cytotoxic T lymphocytes are present even in strictly controlled HIV-1 infection.Elite controllers (EC) of human immunodeficiency virus type 1 (HIV-1) maintain viremia below the limit of detection without antiretroviral treatment. Virus-specific cytotoxic CD8(+) T lymphocytes are believed to play a crucial role in viral containment, but the degree of immune imprinting and compensatory mutations in EC is unclear. We obtained plasma gag, pol, and nef sequences from HLA-diverse subjects and found that 30 to 40% of the predefined HLA-associated polymorphic sites show evidence of immune selection pressure in EC, compared to approximately 50% of the sites in chronic progressors. These data indicate ongoing viral replication and escape from cytotoxic T lymphocytes are present even in strictly controlled HIV-1 infection.
Elite controllers (EC) of human immunodeficiency virus type 1 (HIV-1) maintain viremia below the limit of detection without antiretroviral treatment. Virus-specific cytotoxic CD8(+) T lymphocytes are believed to play a crucial role in viral containment, but the degree of immune imprinting and compensatory mutations in EC is unclear. We obtained plasma gag, pol, and nef sequences from HLA-diverse subjects and found that 30 to 40% of the predefined HLA-associated polymorphic sites show evidence of immune selection pressure in EC, compared to approximately 50% of the sites in chronic progressors. These data indicate ongoing viral replication and escape from cytotoxic T lymphocytes are present even in strictly controlled HIV-1 infection.
Author's Correction ( vol. 84 , p. 1212 ) Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0022-538X Online ISSN: 1098-5514 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to JVI .asm.org, visit: JVI       
Elite controllers (EC) of human immunodeficiency virus type 1 (HIV-1) maintain viremia below the limit of detection without antiretroviral treatment. Virus-specific cytotoxic CD8 + T lymphocytes are believed to play a crucial role in viral containment, but the degree of immune imprinting and compensatory mutations in EC is unclear. We obtained plasma gag , pol , and nef sequences from HLA-diverse subjects and found that 30 to 40% of the predefined HLA-associated polymorphic sites show evidence of immune selection pressure in EC, compared to approximately 50% of the sites in chronic progressors. These data indicate ongoing viral replication and escape from cytotoxic T lymphocytes are present even in strictly controlled HIV-1 infection.
Author Zabrina L. Brumme
P. Richard Harrigan
Chanson J. Brumme
Alicja Trocha
Mina John
Brian L. Block
Simon Mallal
Mark A. Brockman
Florencia Pereyra
Toshiyuki Miura
Bruce D. Walker
AuthorAffiliation Ragon Institute (formerly Partners AIDS Research Center), Massachusetts General Hospital, Charlestown, Massachusetts 02129, 1 Division of AIDS, Harvard Medical School, Boston, Massachusetts 02115, 2 Howard Hughes Medical Institute, Chevy Chase, Maryland 20815, 3 Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Perth, Australia, 4 British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada, 5 Division of AIDS, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada 6
AuthorAffiliation_xml – name: Ragon Institute (formerly Partners AIDS Research Center), Massachusetts General Hospital, Charlestown, Massachusetts 02129, 1 Division of AIDS, Harvard Medical School, Boston, Massachusetts 02115, 2 Howard Hughes Medical Institute, Chevy Chase, Maryland 20815, 3 Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Perth, Australia, 4 British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada, 5 Division of AIDS, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada 6
Author_xml – sequence: 1
  givenname: Toshiyuki
  surname: Miura
  fullname: Miura, Toshiyuki
  organization: Ragon Institute (formerly Partners AIDS Research Center), Massachusetts General Hospital, Charlestown, Massachusetts 02129, Division of AIDS, Harvard Medical School, Boston, Massachusetts 02115, Howard Hughes Medical Institute, Chevy Chase, Maryland 20815
– sequence: 2
  givenname: Chanson J.
  surname: Brumme
  fullname: Brumme, Chanson J.
  organization: Ragon Institute (formerly Partners AIDS Research Center), Massachusetts General Hospital, Charlestown, Massachusetts 02129
– sequence: 3
  givenname: Mark A.
  surname: Brockman
  fullname: Brockman, Mark A.
  organization: Ragon Institute (formerly Partners AIDS Research Center), Massachusetts General Hospital, Charlestown, Massachusetts 02129, Division of AIDS, Harvard Medical School, Boston, Massachusetts 02115
– sequence: 4
  givenname: Zabrina L.
  surname: Brumme
  fullname: Brumme, Zabrina L.
  organization: Ragon Institute (formerly Partners AIDS Research Center), Massachusetts General Hospital, Charlestown, Massachusetts 02129, Division of AIDS, Harvard Medical School, Boston, Massachusetts 02115
– sequence: 5
  givenname: Florencia
  surname: Pereyra
  fullname: Pereyra, Florencia
  organization: Ragon Institute (formerly Partners AIDS Research Center), Massachusetts General Hospital, Charlestown, Massachusetts 02129, Division of AIDS, Harvard Medical School, Boston, Massachusetts 02115
– sequence: 6
  givenname: Brian L.
  surname: Block
  fullname: Block, Brian L.
  organization: Division of AIDS, Harvard Medical School, Boston, Massachusetts 02115
– sequence: 7
  givenname: Alicja
  surname: Trocha
  fullname: Trocha, Alicja
  organization: Ragon Institute (formerly Partners AIDS Research Center), Massachusetts General Hospital, Charlestown, Massachusetts 02129, Howard Hughes Medical Institute, Chevy Chase, Maryland 20815
– sequence: 8
  givenname: Mina
  surname: John
  fullname: John, Mina
  organization: Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Perth, Australia
– sequence: 9
  givenname: Simon
  surname: Mallal
  fullname: Mallal, Simon
  organization: Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Perth, Australia
– sequence: 10
  givenname: P. Richard
  surname: Harrigan
  fullname: Harrigan, P. Richard
  organization: British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada, Division of AIDS, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
– sequence: 11
  givenname: Bruce D.
  surname: Walker
  fullname: Walker, Bruce D.
  organization: Ragon Institute (formerly Partners AIDS Research Center), Massachusetts General Hospital, Charlestown, Massachusetts 02129, Division of AIDS, Harvard Medical School, Boston, Massachusetts 02115, Howard Hughes Medical Institute, Chevy Chase, Maryland 20815
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21261644$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/19153230$$D View this record in MEDLINE/PubMed
BookMark eNqFks9v0zAcxS00xLqNG2dkDnBaNv-Oc0GqqkGLiriMiZvlOM7qybE7Oxnqf09Cu_FDQpwsy5_3_J79PQFHIQYLwCuMLjAm8vLTzeoCEcarAslnYIZRJQvOMTsCM4QIKTiV347BSc53CGHGBHsBjnGFOSUUzUC9XM-Lec7RON3bBt64pD38PPS6dzFkOE8WLmLXxQBdgMuh0wGuum4IsbGtM84Gs5tEQ4bXu62FGF5510-a0KfovU35DDxvtc_25WE9BV8_XF0vlsX6y8fVYr4uDKe8L7QUqOFS19rQEmvOq1riEssSCVTVDSONJFSWrTCWYCzGAi0xiI_bSlvccnoK3u99t0Pd2cbYMYH2aptcp9NORe3UnyfBbdRtfFBEcM6FHA3eHQxSvB9s7lXnsrHe62DjkJUoESaCof-CBFPERDWBr3-P9JTl8f1H4O0B0Nlo3yYdjMtPHBnvw4KxkTvfcybFnJNtf1khNY2BGsdA_RwDhaYm5C_cuP2PjsWd_5fozV60cbeb7y5ZpXOn7h6cklSVijJU0h8_Mb-z
CitedBy_id crossref_primary_10_1186_s12977_017_0354_5
crossref_primary_10_1016_j_virol_2012_10_004
crossref_primary_10_1016_j_immuni_2021_08_007
crossref_primary_10_1016_j_tips_2009_09_005
crossref_primary_10_1128_JVI_06982_11
crossref_primary_10_3389_fimmu_2015_00665
crossref_primary_10_1097_COH_0b013e328361faf4
crossref_primary_10_1371_journal_pone_0137140
crossref_primary_10_1146_annurev_conmatphys_030212_184325
crossref_primary_10_1371_journal_pone_0047818
crossref_primary_10_1371_journal_pone_0103209
crossref_primary_10_1016_j_coviro_2012_08_003
crossref_primary_10_1128_JVI_05841_11
crossref_primary_10_1080_21505594_2022_2129353
crossref_primary_10_1128_JVI_00460_11
crossref_primary_10_4049_jimmunol_0902781
crossref_primary_10_1016_j_pharma_2014_11_002
crossref_primary_10_1128_JVI_02438_09
crossref_primary_10_1016_j_pharma_2014_11_003
crossref_primary_10_1128_JVI_07020_11
crossref_primary_10_1016_j_meegid_2013_02_003
crossref_primary_10_1186_1742_4690_8_63
crossref_primary_10_1038_cmi_2012_50
crossref_primary_10_1038_nri3478
crossref_primary_10_1073_pnas_1105315108
crossref_primary_10_1038_464161a
crossref_primary_10_1155_2012_153863
crossref_primary_10_1038_ni_3161
crossref_primary_10_1038_nm_4100
crossref_primary_10_1007_s00430_014_0372_z
crossref_primary_10_1590_0074_02760230066
crossref_primary_10_1371_journal_pone_0063094
crossref_primary_10_1016_j_immuni_2011_07_005
crossref_primary_10_1128_JVI_00387_10
crossref_primary_10_1073_pnas_1302090110
crossref_primary_10_1128_JVI_01334_14
crossref_primary_10_1016_j_immuni_2012_09_005
crossref_primary_10_1089_vim_2009_0084
crossref_primary_10_1128_JVI_00803_10
crossref_primary_10_1016_j_heliyon_2024_e30900
crossref_primary_10_1038_s41577_020_0274_9
crossref_primary_10_1097_QAD_0b013e32835861b0
crossref_primary_10_1073_pnas_1221555110
crossref_primary_10_1128_JVI_01527_15
crossref_primary_10_1007_s00109_012_0892_1
crossref_primary_10_1097_QAD_0000000000003296
crossref_primary_10_1089_aid_2014_0040
crossref_primary_10_1016_j_antib_2010_04_001
crossref_primary_10_1155_2012_637208
crossref_primary_10_1097_COH_0b013e32832c0672
crossref_primary_10_1097_QAD_0b013e32833e5009
crossref_primary_10_1128_JVI_06728_11
crossref_primary_10_1128_JVI_06724_11
crossref_primary_10_1172_JCI171097
crossref_primary_10_1371_journal_ppat_1003423
crossref_primary_10_1111_imr_12076
crossref_primary_10_1007_s00705_010_0659_3
Cites_doi 10.1128/JVI.01847-06
10.1128/jvi.68.7.4650-4655.1994
10.1128/JVI.80.10.4758-4770.2006
10.1038/nm1520
10.1038/nm0297-212
10.1038/ni1281
10.1084/jem.20031982
10.1128/JVI.01369-07
10.1128/JVI.01958-08
10.1086/514112
10.1128/JVI.00580-08
10.1073/pnas.94.5.1890
10.1128/JVI.77.12.6889-6898.2003
10.1128/JVI.00535-08
10.4049/jimmunol.174.12.7524
10.1128/JVI.02165-06
10.1097/QAD.0b013e3283021a8c
10.1128/JVI.80.10.5074-5077.2006
10.1084/jem.20052319
10.1128/JVI.02392-06
10.1128/JVI.01471-08
10.1371/journal.ppat.0030094
10.1126/science.283.5403.857
10.1128/JVI.80.6.3122-3125.2006
10.1086/526786
10.1038/nm0496-405
10.1128/JVI.77.4.2736-2740.2003
10.1038/nm992
10.1128/jvi.68.4.2362-2370.1994
10.1038/35030124
10.1128/JVI.80.7.3617-3623.2006
ContentType Journal Article
Copyright 2009 INIST-CNRS
Copyright © 2009, American Society for Microbiology
Copyright_xml – notice: 2009 INIST-CNRS
– notice: Copyright © 2009, American Society for Microbiology
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7U9
H94
7X8
5PM
DOI 10.1128/JVI.02459-08
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
Immunology Abstracts
Virology and AIDS Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
AIDS and Cancer Research Abstracts


CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1098-5514
EndPage 3412
ExternalDocumentID PMC2655568
19153230
21261644
10_1128_JVI_02459_08
jvi_83_7_3407
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: R37 AI028568
– fundername: NIAID NIH HHS
  grantid: R01 AI030914
– fundername: Howard Hughes Medical Institute
– fundername: NIAID NIH HHS
  grantid: AI028568
– fundername: NIAID NIH HHS
  grantid: R01 AI028568
– fundername: NIAID NIH HHS
  grantid: AI030914
– fundername: NIAID NIH HHS
  grantid: P30 AI060354
GroupedDBID ---
-~X
.55
.GJ
0R~
18M
29L
2WC
39C
3O-
4.4
41~
53G
5GY
5RE
5VS
6TJ
85S
AAFWJ
AAGFI
AAYJJ
AAYXX
ABPPZ
ACGFO
ACNCT
ADBBV
ADXHL
AENEX
AFFNX
AGVNZ
AI.
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
C1A
CITATION
CS3
D0S
DIK
E3Z
EBS
EJD
F5P
FRP
GX1
H13
HYE
HZ~
IH2
KQ8
MVM
N9A
O9-
OHT
OK1
P2P
RHI
RNS
RPM
RSF
TR2
UPT
VH1
W2D
W8F
WH7
WOQ
X7M
Y6R
YQT
ZGI
ZXP
~02
~KM
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7U9
H94
7X8
5PM
ID FETCH-LOGICAL-c535t-a860d58abac371a559b8171870609bd42d82387f6ce2116153f2c056ce9ae1f53
ISSN 0022-538X
1098-5514
IngestDate Thu Aug 21 18:31:46 EDT 2025
Fri Sep 05 06:05:38 EDT 2025
Fri Sep 05 11:00:43 EDT 2025
Thu Apr 03 07:07:04 EDT 2025
Mon Jul 21 09:14:31 EDT 2025
Thu Apr 24 23:01:30 EDT 2025
Tue Jul 01 00:57:31 EDT 2025
Wed May 18 15:25:39 EDT 2016
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords Immunopathology
HLA-System
HIV-1 virus
Retroviridae
AIDS
Immune deficiency
Lentivirus
Virology
Infection
Virus
Viral disease
Human immunodeficiency virus
Mutation
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c535t-a860d58abac371a559b8171870609bd42d82387f6ce2116153f2c056ce9ae1f53
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
Corresponding author. Present address of Toshiyuki Miura: Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan. Phone: 81-3-5449-5338. Fax: 81-3-5449-5427. E-mail: miura523@hotmail.com. Mailing address for Bruce D. Walker: Room 5212, Ragon Institute, Massachusetts General Hospital, 149 13th St., Charlestown, MA 02129. Phone: (617) 724-8332. Fax: (617) 726-4691. E-mail: bwalker@partners.org
OpenAccessLink http://doi.org/10.1128/JVI.02459-08
PMID 19153230
PQID 21304690
PQPubID 23462
PageCount 6
ParticipantIDs proquest_miscellaneous_67012640
crossref_primary_10_1128_JVI_02459_08
proquest_miscellaneous_21304690
highwire_asm_jvi_83_7_3407
crossref_citationtrail_10_1128_JVI_02459_08
pubmed_primary_19153230
pubmedcentral_primary_oai_pubmedcentral_nih_gov_2655568
pascalfrancis_primary_21261644
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2009-04-01
PublicationDateYYYYMMDD 2009-04-01
PublicationDate_xml – month: 04
  year: 2009
  text: 2009-04-01
  day: 01
PublicationDecade 2000
PublicationPlace Washington, DC
PublicationPlace_xml – name: Washington, DC
– name: United States
PublicationTitle Journal of Virology
PublicationTitleAlternate J Virol
PublicationYear 2009
Publisher American Society for Microbiology
American Society for Microbiology (ASM)
Publisher_xml – name: American Society for Microbiology
– name: American Society for Microbiology (ASM)
References e_1_3_2_26_2
e_1_3_2_27_2
e_1_3_2_28_2
e_1_3_2_29_2
e_1_3_2_20_2
e_1_3_2_21_2
e_1_3_2_22_2
e_1_3_2_23_2
e_1_3_2_24_2
e_1_3_2_25_2
e_1_3_2_9_2
e_1_3_2_15_2
e_1_3_2_8_2
e_1_3_2_16_2
e_1_3_2_7_2
e_1_3_2_6_2
e_1_3_2_18_2
e_1_3_2_19_2
e_1_3_2_30_2
e_1_3_2_32_2
e_1_3_2_10_2
e_1_3_2_31_2
e_1_3_2_5_2
e_1_3_2_11_2
e_1_3_2_34_2
e_1_3_2_4_2
e_1_3_2_12_2
e_1_3_2_33_2
e_1_3_2_3_2
e_1_3_2_13_2
e_1_3_2_2_2
e_1_3_2_14_2
(e_1_3_2_17_2) 2008
15067030 - J Exp Med. 2004 Apr 5;199(7):905-15
J Virol. 2010 Jan;84(2):1212
12768008 - J Virol. 2003 Jun;77(12):6889-98
16369537 - Nat Immunol. 2006 Feb;7(2):173-8
16501126 - J Virol. 2006 Mar;80(6):3122-5
12552014 - J Virol. 2003 Feb;77(4):2736-40
14770175 - Nat Med. 2004 Mar;10(3):282-9
16641269 - J Virol. 2006 May;80(10):4758-70
17151109 - J Virol. 2007 Mar;81(5):2508-18
8207839 - J Virol. 1994 Jul;68(7):4650-5
9018241 - Nat Med. 1997 Feb;3(2):212-7
9359718 - J Infect Dis. 1997 Nov;176(5):1188-97
16641299 - J Virol. 2006 May;80(10):5074-7
18580606 - AIDS. 2008 Jul 11;22(11):1277-86
17251286 - J Virol. 2007 Apr;81(7):3465-76
15944251 - J Immunol. 2005 Jun 15;174(12):7524-30
16682496 - J Exp Med. 2006 May 15;203(5):1357-69
17182686 - J Virol. 2007 Mar;81(5):2440-8
16537629 - J Virol. 2006 Apr;80(7):3617-23
18596105 - J Virol. 2008 Sep;82(17):8548-59
11014195 - Nature. 2000 Sep 21;407(6802):386-90
8139022 - J Virol. 1994 Apr;68(4):2362-70
18945771 - J Virol. 2009 Jan;83(1):88-97
18971283 - J Virol. 2009 Jan;83(1):140-9
9933172 - Science. 1999 Feb 5;283(5403):857-60
17616974 - PLoS Pathog. 2007 Jul;3(7):e94
18275276 - J Infect Dis. 2008 Feb 15;197(4):563-71
18562530 - J Virol. 2008 Sep;82(17):8422-30
17173051 - Nat Med. 2007 Jan;13(1):46-53
17728232 - J Virol. 2007 Nov;81(22):12608-18
8597949 - Nat Med. 1996 Apr;2(4):405-11
9050875 - Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1890-5
References_xml – ident: e_1_3_2_15_2
  doi: 10.1128/JVI.01847-06
– ident: e_1_3_2_21_2
  doi: 10.1128/jvi.68.7.4650-4655.1994
– ident: e_1_3_2_4_2
  doi: 10.1128/JVI.80.10.4758-4770.2006
– ident: e_1_3_2_20_2
  doi: 10.1038/nm1520
– ident: e_1_3_2_9_2
– ident: e_1_3_2_16_2
  doi: 10.1038/nm0297-212
– ident: e_1_3_2_13_2
  doi: 10.1038/ni1281
– ident: e_1_3_2_11_2
  doi: 10.1084/jem.20031982
– ident: e_1_3_2_7_2
  doi: 10.1128/JVI.01369-07
– ident: e_1_3_2_3_2
  doi: 10.1128/JVI.01958-08
– ident: e_1_3_2_19_2
  doi: 10.1086/514112
– ident: e_1_3_2_24_2
  doi: 10.1128/JVI.00580-08
– ident: e_1_3_2_30_2
  doi: 10.1073/pnas.94.5.1890
– ident: e_1_3_2_25_2
  doi: 10.1128/JVI.77.12.6889-6898.2003
– ident: e_1_3_2_26_2
  doi: 10.1128/JVI.00535-08
– ident: e_1_3_2_12_2
  doi: 10.4049/jimmunol.174.12.7524
– ident: e_1_3_2_6_2
  doi: 10.1128/JVI.02165-06
– ident: e_1_3_2_10_2
  doi: 10.1097/QAD.0b013e3283021a8c
– ident: e_1_3_2_33_2
  doi: 10.1128/JVI.80.10.5074-5077.2006
– ident: e_1_3_2_5_2
  doi: 10.1084/jem.20052319
– ident: e_1_3_2_14_2
  doi: 10.1128/JVI.02392-06
– start-page: 312
  year: 2008
  ident: e_1_3_2_17_2
  publication-title: 15th Conference on Retroviruses and Opportunistic Infection.
– ident: e_1_3_2_27_2
  doi: 10.1128/JVI.01471-08
– ident: e_1_3_2_8_2
  doi: 10.1371/journal.ppat.0030094
– ident: e_1_3_2_32_2
  doi: 10.1126/science.283.5403.857
– ident: e_1_3_2_34_2
  doi: 10.1128/JVI.80.6.3122-3125.2006
– ident: e_1_3_2_29_2
  doi: 10.1086/526786
– ident: e_1_3_2_18_2
  doi: 10.1038/nm0496-405
– ident: e_1_3_2_28_2
  doi: 10.1128/JVI.77.4.2736-2740.2003
– ident: e_1_3_2_22_2
  doi: 10.1038/nm992
– ident: e_1_3_2_31_2
  doi: 10.1128/jvi.68.4.2362-2370.1994
– ident: e_1_3_2_2_2
  doi: 10.1038/35030124
– ident: e_1_3_2_23_2
  doi: 10.1128/JVI.80.7.3617-3623.2006
– reference: 8207839 - J Virol. 1994 Jul;68(7):4650-5
– reference: 16501126 - J Virol. 2006 Mar;80(6):3122-5
– reference: 9018241 - Nat Med. 1997 Feb;3(2):212-7
– reference: 16641269 - J Virol. 2006 May;80(10):4758-70
– reference: 9359718 - J Infect Dis. 1997 Nov;176(5):1188-97
– reference: 9933172 - Science. 1999 Feb 5;283(5403):857-60
– reference: 17182686 - J Virol. 2007 Mar;81(5):2440-8
– reference: 16369537 - Nat Immunol. 2006 Feb;7(2):173-8
– reference: 11014195 - Nature. 2000 Sep 21;407(6802):386-90
– reference: 15944251 - J Immunol. 2005 Jun 15;174(12):7524-30
– reference: 18275276 - J Infect Dis. 2008 Feb 15;197(4):563-71
– reference: 17151109 - J Virol. 2007 Mar;81(5):2508-18
– reference: 14770175 - Nat Med. 2004 Mar;10(3):282-9
– reference: 9050875 - Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1890-5
– reference: - J Virol. 2010 Jan;84(2):1212
– reference: 15067030 - J Exp Med. 2004 Apr 5;199(7):905-15
– reference: 16537629 - J Virol. 2006 Apr;80(7):3617-23
– reference: 17728232 - J Virol. 2007 Nov;81(22):12608-18
– reference: 18562530 - J Virol. 2008 Sep;82(17):8422-30
– reference: 18971283 - J Virol. 2009 Jan;83(1):140-9
– reference: 8139022 - J Virol. 1994 Apr;68(4):2362-70
– reference: 17173051 - Nat Med. 2007 Jan;13(1):46-53
– reference: 18945771 - J Virol. 2009 Jan;83(1):88-97
– reference: 17616974 - PLoS Pathog. 2007 Jul;3(7):e94
– reference: 12552014 - J Virol. 2003 Feb;77(4):2736-40
– reference: 17251286 - J Virol. 2007 Apr;81(7):3465-76
– reference: 18580606 - AIDS. 2008 Jul 11;22(11):1277-86
– reference: 12768008 - J Virol. 2003 Jun;77(12):6889-98
– reference: 16641299 - J Virol. 2006 May;80(10):5074-7
– reference: 16682496 - J Exp Med. 2006 May 15;203(5):1357-69
– reference: 8597949 - Nat Med. 1996 Apr;2(4):405-11
– reference: 18596105 - J Virol. 2008 Sep;82(17):8548-59
SSID ssj0014464
Score 2.2142231
Snippet Author's Correction ( vol. 84 , p. 1212 ) Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike...
Elite controllers (EC) of human immunodeficiency virus type 1 (HIV-1) maintain viremia below the limit of detection without antiretroviral treatment....
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
highwire
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 3407
SubjectTerms Biological and medical sciences
Epitopes, T-Lymphocyte - genetics
Epitopes, T-Lymphocyte - immunology
Fundamental and applied biological sciences. Psychology
gag Gene Products, Human Immunodeficiency Virus - genetics
HIV Infections - immunology
HIV Infections - virology
HIV Long-Term Survivors
HIV-1 - genetics
HIV-1 - immunology
Human immunodeficiency virus 1
Humans
Microbiology
Miscellaneous
Mutation, Missense - immunology
nef Gene Products, Human Immunodeficiency Virus - genetics
Pathogenesis and Immunity
Plasma - virology
pol Gene Products, Human Immunodeficiency Virus - genetics
Polymorphism, Genetic
Selection, Genetic
Viral Load
Viremia - immunology
Virology
Title HLA-Associated Viral Mutations Are Common in Human Immunodeficiency Virus Type 1 Elite Controllers
URI http://jvi.asm.org/content/83/7/3407.abstract
https://www.ncbi.nlm.nih.gov/pubmed/19153230
https://www.proquest.com/docview/21304690
https://www.proquest.com/docview/67012640
https://pubmed.ncbi.nlm.nih.gov/PMC2655568
Volume 83
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKEBIviDsdMPwAT1VH49ycxzANtds6pGode7OcxNECI0VLgjR-Cr-Wc5w4SatOXF6iKnFSK9-X43N8boS8BZXaYQkLQPqpdOxEPshB5SiwWmOwJwLtGcNoi1NvunSOLtyLweBXL2qpKqP9-OfWvJL_QRXOAa6YJfsPyLYPhRPwG_CFIyAMx7_CeHoSjs37BcXxPMNs-3lVNuFt4TX2pMPp4K5GvV0_w3yQVaKwcITOuoSbqmKE5ujIwiCvEu_R4etXTXD8Ft0Vk-P62_Hz2XIRauhXxWV2U33NWjN_AWL7sHHsY6JZ54f6HJ4c13EYmmBd7PGHxaeD43l4anKJmv1WszcR9EJaunQAlFO9CNR51lWY6ktmNIpt3Wa4lcx1i5uGgX5PzNpO3Sq3WbJhJWbblwOGKQ5H57N99DDD9Hi37BlX_8Zq2MYowprugS3p3CF3me_rEAC9E9R4qMCMdkwlepy3Sapg_H3__9bVHVOCGiNwZQEfYVp3T9lm3mxG6fbUnrOH5EGDOQ1r8j0iA5U_JvfqDqY3T0i0TkGqKUhbCsJ9itYUpFlONQXpJgWppiBFClKLagrSHgWfkuXHw7OD6bhp2zGOXdstx5J7k8TlMpKx7VsSTNaIW6ACYZ2mIEpANHDQE_0Ue9FZ2uBIWQx6eKwCqazUtZ-RnXyVqxeEpilLpUxUlEjQoiY88ljgxY6na1Rxhw3JyLxdETc17bG1ypXQti3jArAQGgsx4UPyrh39va7lcsu4XQOUkMU38eVHJrgtfIG0G5K9NejaJxm-DMkbg6UAUY3-N5mrVVXACFvvRt0-wvNBX_QcGPG8xr6bZwDvidlwxV9jRTsAy8SvX8mzS10unnkulhnc_dPEX5L73Tf8iuyU15V6DRp3Ge1p6v8GtTvWpw
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=HLA-Associated+Viral+Mutations+Are+Common+in+Human+Immunodeficiency+Virus+Type+1+Elite+Controllers&rft.jtitle=Journal+of+virology&rft.au=MIURA%2C+Toshiyuki&rft.au=BRUMME%2C+Chanson+J&rft.au=WALKER%2C+Bruce+D&rft.au=BROCKMAN%2C+Mark+A&rft.date=2009-04-01&rft.pub=American+Society+for+Microbiology&rft.issn=0022-538X&rft.volume=83&rft.issue=7&rft.spage=3407&rft.epage=3412&rft_id=info:doi/10.1128%2FJVI.02459-08&rft.externalDBID=n%2Fa&rft.externalDocID=21261644
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon